glaucoma_description_and_case_study.pptx

Gnanammal1 114 views 29 slides Sep 01, 2025
Slide 1
Slide 1 of 29
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29

About This Presentation

Glaucoma is one of the leading causes of irreversible blindness worldwide, often progressing silently until significant vision loss has occurred. This presentation provides a clear overview of the disease—covering basic anatomy, aqueous humor dynamics, and what happens when drainage problems arise...


Slide Content

Glaucoma: The Silent Thief of Sight Presented by: GNANAMMAL ( B.Optom 3rd Year) INSTITUTE OF MANAGEMENT STUDY

BASIC ANATOMY

AQUEOUS HUMOR

WHAT IF THERE IS DRAINAGE PROBLEM?

A group of progressive optic neuropathies Characterized by optic nerve damage and visual field loss Usually associated with raised IOP (but can occur with normal IOP too) What is Glaucoma?

1.Primary Primary Open Angle Glaucoma (POAG) Primary Angle Closure Glaucoma (PACG) Normal Tension Glaucoma (NTG) 2.Secondary – trauma, uveitis, lens, neovascular 3.Congenital Classification:

Open Angle Glaucoma Most common type Gradual, painless, bilateral Risk factors: Age > 40, family history, myopia, diabetes Clinical: Raised IOP, optic disc cupping, peripheral visual field loss Often asymptomatic until late

Closed Angle Glaucoma Sudden rise of IOP due to blocked drainage angle Symptoms: Severe ocular pain, redness, halos, headache, nausea, vomiting Signs: Mid-dilated pupil, corneal edema, conjunctival congestion Ophthalmic emergency

Normal Tension Glaucoma Optic nerve damage and field loss despite normal IOP Risk factors: Vascular dysregulation, low BP, migraine, ischemia More common in Asian population Needs careful diagnosis

Cupping of the optic disc

Diagnosis Tonometry (IOP measurement) Gonioscopy (angle evaluation) Fundus exam – optic disc cupping Visual field testing – tunnel vision, arcuate scotomas OCT – retinal nerve fiber layer (RNFL) thinning

Medical: Prostaglandin analogs (Latanoprost) – 1st line(POAG) Beta blockers (Timolol) Carbonic anhydrase inhibitors Miotics (Pilocarpine in PACG) Laser/Surgery: Laser trabeculoplasty / iridotomy Trabeculectomy Minimally Invasive Glaucoma Surgery Glaucoma Drainage Implants Management

CASE STUDY Case-1

Patient Name: XYA Age/Sex: 56/M Date: 20-08-2025 Reason for visit: First eye check. Night glare. Occasional brow ache for 6 months. History: No prior eye exams. No trauma or steroid use. HTN ×6 yrs (Amlodipine 5 mg). Father had high eye pressure. No allergies. Non-smoker.

Exam: VA (pinhole): 6/6 OD, 6/6 OS Refraction: −1.25 DS OU, +2.50 DS N6 Pupils/EOM: Normal, no RAPD Slit lamp: Clear cornea, deep quiet AC, early NS 1+ OU IOP (Goldmann, 10:30 a.m.): 26 OD / 24 OS (mmHg) CCT (µm): 520 OD / 515 OS Gonioscopy: Shaffer 3–4, TM seen 360°, no PAS OU Optic disc: OD C/D 0.7V with inferior rim thinning; OS C/D 0.6, rims intact Macula/periphery: WNL OU

Tests (baseline) HVF 24-2: OD superior nasal step (MD −3.2 dB); OS essentially full OCT RNFL/GCIPL: Inferior thinning OD; OS borderline inferior Disc photos taken Impression Early POAG OD. Fellow eye: glaucoma suspect. Thin corneas increase risk. Management Plan Start Latanoprost 0.005% 1 drop at night OU Target IOP: ≤18 mmHg Teach drop technique + punctal occlusion Follow-up 6 weeks for IOP check and tolerance → then 3–4 monthly if stable. Repeat OCT + fields at 6 months, then yearly or sooner if change.

CASE STUDY Case-2

Name: Mrs. XYZ Age/Sex: 54-year-old female Occupation: School teacher Chief Complaints OD (Right Eye): Severe pain, redness, blurred vision, and colored halos around lights for the past 10–12 hours, associated with nausea and headache. OS (Left Eye): Occasional blurring of vision and mild headache for the past few weeks. History Ocular History: no trauma or ocular surgery Family History: Positive (elder sister diagnosed with angle closure glaucoma) Medical History: Hypertension since 2 years(controlled on medication), no history of diabetes Allergies : Not aware of PGP: Reading Glasses: +2.25DS

Initial Management: Acute Attack (OD): IV Mannitol 20% 250 mL stat Oral Acetazolamide 500 mg stat, then 250 mg QID Topical Timolol 0.5% BD, Pilocarpine 2% QID, and Prednisolone acetate 1% QID OS (Prophylaxis): Timolol 0.5% BD started

Investigations: 1. OCT RNFL: OD: Superior & inferior thinning OS: Early superior thinning 2. Visual Field Testing (after stabilization): OD: Superior arcuate defect OS: Early nasal step 3. Anterior Segment OCT (AS-OCT): OU :Narrow angles

Day 2: Laser Intervention Bilateral Laser Peripheral Iridotomy (LPI) performed after OD corneal edema cleared .

Follow-up Visit 1 (1 Week Post LPI) Symptoms: Pain and halos resolved Continue Timolol OU, taper steroid OD.

Follow-up Visit 2 (3 Months Post LPI) Continue Timolol OU Monitor every 3–4 months patient counselled on adherence and early reporting of symptoms

Final Diagnosis: Primary Angle Closure Glaucoma OD: Advanced OS: Early stage

Is Glaucoma Preventable? No absolute prevention → as exact cause is not fully understood But progression can be slowed if detected early Why not preventable? -Often asymptomatic in early stages → late diagnosis -Damage to optic nerve is irreversible

Take Home Message Regular eye check-ups (especially after 40 yrs or if high risk) Family history → early screening Compliance with treatment to maintain vision

THANK YOU!